SecBot SecBot
SC 14D-9/A ·Filed Nov 17, 2026

PCRX

Pacira BioSciences, Inc.
MIXED
Impact 8/10
Horizonimmediate Processed4d 22h ago SEC0001140361-26-044349
Notable filing: SC 14D-9/A
Actionable Insight ◆ Mixed

The merger is complete; PCRX shares will be delisted and deregistered. Holders who did not tender should contact their broker or the depositary to receive the $36.50 per share consideration. No further trading or corporate events are expected.

DirectionMixed
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

Executive Summary

Pacira BioSciences filed Amendment No. 3 to its Schedule 14D-9 confirming that Viatris's tender offer expired on November 16, 2026, with 32,929,780 shares (66.46%) validly tendered. All conditions were satisfied, and on November 17, 2026, the merger was consummated, making Pacira a wholly owned subsidiary of Viatris at $36.50 per share in cash. The shares will be delisted from Nasdaq.

Key Facts

  • Tender offer expired November 16, 2026 with 32,929,780 shares (66.46%) validly tendered
  • Offer price: $36.50 per share in cash
  • All conditions satisfied or waived; Purchaser accepted shares on November 17, 2026
  • Merger consummated on November 17, 2026 under Section 251(h) of DGCL
  • Pacira became a wholly owned subsidiary of Viatris
  • Shares to be delisted from Nasdaq Global Select Market and deregistered

Financial Impact

Acquisition of Pacira for $36.50 per share in cash; total consideration based on ~49.5M shares outstanding (implied ~$1.8B enterprise value)

share pricemarket capownership structure

Risk Factors

  • Potential appraisal/valuation proceedings by stockholders who perfected dissenters' rights
  • Delisting and deregistration eliminate public market liquidity

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 14D-9/A Filing (Primary)0001140361-26-044349
Document: 0001140361-26-044349-index-headers.html0001140361-26-044349
Document: 0001140361-26-044349-index.html0001140361-26-044349
Document: 0001140361-26-044349.txt0001140361-26-044349

Track record

33 reports on PCRX

Performance horizon

5 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +42.26% at T+60 after the Aug 6, 2026 report. 8 of 9 went positive at some point.

Filters
  1. Nov 17, 20264d ago 8-K Mixed 8/10 Entry $36.48 Now $36.48 −0.00% settles Dec 16
  2. Nov 17, 20264d ago SC 14D-9/A Mixed 8/10 Viewing Entry $36.48 Now $36.48 −0.00% settles Dec 16
  3. Nov 17, 20264d ago SC TO-T/A Mixed 7/10 Entry $36.48 Now $36.48 −0.00% settles Dec 16
  4. Nov 17, 20264d ago 25-NSE Neutral 1/10 Entry $36.48 Now $36.48 −0.00% settles Dec 16
  5. Nov 12, 20269d ago 8-K Bearish 6/10 Entry $36.46 Now $36.48 −0.05% settles Dec 14
  6. Nov 12, 20269d ago SC TO-T/A Mixed 7/10 Entry $36.46 Now $36.48 +0.05% settles Dec 14
  7. Nov 12, 20269d ago SC 14D-9/A Neutral 3/10 Entry $36.46 Now $36.48 +0.05% settles Dec 14
  8. Nov 5, 202616d ago 8-K Neutral 5/10 Entry $36.43 Now $36.48 +0.14% settles Dec 7
  9. Nov 3, 202618d ago SC 14D-9/A Neutral 3/10 Entry $36.40 Now $36.48 +0.22% settles Dec 3
  10. Oct 30, 202622d ago SC 13G/A Neutral 2/10 Entry $36.39 Now $36.48 +0.25% settles Nov 30
Showing 10 of 33

US Market Status

Market Closed · Opens Mon (26h 3m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 17, 2026